VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
International Flavors & Fragrances Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
International Flavors & Fragrances Inc.
IFF · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into International Flavors & Fragrances Inc.'s moat claims, evidence, and risks.
View IFF analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 59 / 100 for International Flavors & Fragrances Inc.).
- Segment focus: International Flavors & Fragrances Inc. has 4 segments (31.2% in Food Ingredients); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: International Flavors & Fragrances Inc. has 8 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
International Flavors & Fragrances Inc.
Food Ingredients
Specialty food ingredients (texturizers, food protection, plant proteins, emulsifiers, sweeteners)
Global
B2B (food manufacturers)
Ingredient supplier
31.2%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
International Flavors & Fragrances Inc. strengths
Sanofi strengths
Segment mix
International Flavors & Fragrances Inc. segments
Full profile >Taste
Oligopoly
Food Ingredients
Competitive
Health & Biosciences
Oligopoly
Scent
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.